diabetes
Conditions
Interventions
Control group:conventional therapy
Sponsors
Taizhou First People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Provision of informed consent prior to any study specific procedures; 2. Type 2 diabetes mellitus; 3. Cardiovascular disease; 4. Uninterrupted anti-diabetic treatment for at least 8 weeks before enrolment.
Exclusion criteria
Exclusion criteria: 1. Patients with type 1 diabetes or diabetes insipidus; 2. Patients with 3 or more oral anti-hyperglycaemic drugs with or without insulin and/or poorly controlled diabetes; 3. Subjects who have history of unstable or rapidly progressing renal disease; 4. Subjects who have severe hepatic insufficiency and/or significant abnormal liver function; 5. Significant cardiovascular history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated Hemoglobin, Type A1C, HbA1c;Fasting blood glucose;Incidence of hypoglycemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;Triglyceride; | — |
Countries
China
Contacts
Public ContactZhu Shuang
Taizhou First People's Hospital
Outcome results
None listed